News|Articles|August 1, 2001

Pharmaceutical Technology

  • Pharmaceutical Technology-08-01-2001
  • Volume 2001 Supplement
  • Issue 2

Stakes Rise for Blown Batches

Author(s)Jim Miller

The vulnerability of both the sponsors and the contractors has increased tremendously.


Related to this article

CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.